High serum follistatin levels in women with ovarian endometriosis

Human Reproduction

Volumn 24, Issue 10, 2009, Pages 2600-2606

  Florio, P ^a   Reis, F M ^b   Torres, P B ^a   Calonaci, F ^a   Abrao, M S ^c   Nascimento, L L ^b   Franchini, M ^d   Cianferoni, L ^d   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Day Surgery Free Standing Unit Palagi   (Italy)

Author keywords

CA 125; Diagnostic accuracy; Endometriosis; Follistatin; Ovarian cyst

Indexed keywords

CA 125 ANTIGEN; FOLLISTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; CYST FLUID; DIAGNOSTIC ACCURACY; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; OVARY CYST; OVARY ENDOMETRIOSIS; PERITONEAL FLUID; PROTEIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIOSIS; FEMALE; FOLLISTATIN; HUMANS; OVARIAN DISEASES;

EID: 70349454115     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep195     Document Type: Article

References (34)

1. Abrão MS, Podgaec S, Filho BM, Ramos LO, Pinotti JA, de Oliveira RM. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod 1997;12:2523-2527.
2. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997;67:817-821.
3. de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJ. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996;116:105-114.
4. Eldar -Geva T, Spitz IM, Groome NP, Margalioth EJ, Homburg R. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Hum Reprod 2001;16:2552-2556.
5. Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P. Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 2001;76:929-935.
6. Ferreira MC, Witz CA, Hammes LS, Kirma N, Petraglia F, Schenken RS, Reis FM. Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum. Mol Hum Reprod 2008;14:301-307.
7. Florio P, Luisi S, Vigano P, Busacca M, Fadalti M, Genazzani AR, Petraglia F. Healthy women and patients with endometriosis show high concentrations of inhibin A, inhibin B, and activin A in peritoneal .uid throughout the menstrual cycle. Hum Reprod 1998;13:2606-2611.
8. Florio P, Severi FM, Luisi S, Ciarmela P, Calonaci G, Cobellis L, Petraglia F. Endometrial expression and secretion of activin A, but not follistatin, increase in the secretory phase of the menstrual cycle. J Soc Gynecol Investig 2003;10:237-243.
9. Foster CM, Olton PR, Padmanabhan V. Diurnal changes in FSH-regulatory peptides and their relationship to gonadotrophins in pubertal girls. Hum Reprod 2005;20:543-548.
10. Giudice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-1799.
11. Gupta S, Agarwal A, Sekhon L, Krajcir N, Cocuzza M, Falcone T. Serum and peritoneal abnormalities in endometriosis: potential use as diagnostic markers. Minerva Ginecol 2006;58:527-551.
12. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983;148:839-843.
13. Jones RL, Salamonsen LA, Findlay JK. Activin A promotes human endometrial stromal cell decidualization in vitro. J Clin Endocrinol Metab 2002a;87:4001-4004.
14. Jones RL, Salamonsen LA, Zhao YC, Ethier JF, Drummond AE, Findlay JK. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol Hum Reprod 2002b;8:363-374.
15. Jones KL, de Kretser DM, Patella S, Phillips DJ. Activin A and follistatin in systemic in.ammation. Mol Cell Endocrinol 2004;225:119-125.
16. Kettel LM, DePaolo LV, Morales AJ, Apter D, Ling N, Yen SS. Circulating levels of follistatin from puberty to menopause. Fertil Steril 1996; 65:472-476.
17. Khoury RH, Wang QF, Crowley WF Jr, Hall JE, Schneyer AL, Toth T, Midgley AR Jr, Sluss PM. Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J Clin Endocrinol Metab 1995;80:1361-1368.
18. Kozian DH, Ziche M, Augustin HG. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab Invest 1997;76:267-276.
19. Krneta J, Kroll J, Alves F, Prahst C, Sananbenesi F, Dullin C, Kimmina S, Phillips DJ, Augustin HG. Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors. Cancer Res 2006;66:5686-5695.
20. Kumar TR. Too many follistatins: racing inside and getting out of the cell. Endocrinology 2005;146:5048-5051.
21. Lin SD, Kawakami T, Ushio A, Sato A, Sato S, Iwai M, Endo R, Takikawa Y, Suzuki K. Ratio of circulating follistatin and activin A re.ects the severity of acute liver injury and prognosis in patients with acute liver failure. J Gastroenterol Hepatol 2006;21:374-380.
22. McCarthy SA, Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 1993;268:23066-23071.
23. Menon U, Riley SC, Thomas J, Bose C, Dawnay A, Evans LW, Groome NP, Jacobs IJ. Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma. BJOG 2000;107:1069-1074.
24. Michel U, Ebert S, Phillips D, Nau R. Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 2003;148:559-564.
25. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van d V, Bossuyt PM. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998;70:1101-1108.
26. Muttukrishna S, Tannetta D, Groome N, Sargent I. Activin and follistatin in female reproduction. Mol Cell Endocrinol 2004;225:45-56.
27. Panopoulou E,MurphyC, RasmussenH,Bagli E,Rofstad EK, FotsisT. ActivinA suppresses neuroblastoma xenograft tumor growth via antimitotic and antiangiogenic mechanisms. Cancer Res 2005;65:1877-1886.
28. Prakash A, Li TC, Tuckerman E, Laird S, Wells M, Ledger WL. A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage. Fertil Steril 2006; 86:1723-1730.
29. Reis FM, Di Blasio AM, Florio P, Ambrosini G, Di Loreto C, Petraglia F. Evidence for local production of inhibin A and activin A in patients with ovarian endometriosis. Fertil Steril 2001;75:367-373.
30. Reis FM,Nascimento LL, TsigkouA, FerreiraMC, Luisi S, Petraglia F. Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding. Reprod Sci 2007;14:383-389.
31. Rombauts L, Donoghue J, Cann L, Jones RL, Healy DL. Activin-A secretion is increased in the eutopic endometrium from women with endometriosis. Aust N Z J Obstet Gynaecol 2006;46:148-153.
32. Schneyer AL, Wang Q, Sidis Y, Sluss PM. Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. J Clin Endocrinol Metab 2004;89:5067-5075.
33. Somigliana E, Vigano P, Candiani M, Felicetta I, Di Blasio AM, Vignali M. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis. Fertil Steril 2002;77:1028-1031.
34. Torres PB, Florio P, Ferreira MC, Torricelli M, Reis FM, Petraglia F. Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. Fertil Steril 2007;88: 200-205.